Repare Therapeutics Inc
NASDAQ:RPTX
Repare Therapeutics Inc
Revenue
Repare Therapeutics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Revenue
$51.1m
|
CAGR 3-Years
700%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Revenue
$76m
|
CAGR 3-Years
25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Revenue
$78.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Revenue
$2.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Revenue
$175.5m
|
CAGR 3-Years
52%
|
CAGR 5-Years
223%
|
CAGR 10-Years
68%
|
|
Spectral Medical Inc
TSX:EDT
|
Revenue
CA$1.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-5%
|
Repare Therapeutics Inc
Revenue Breakdown
Breakdown by Geography
Repare Therapeutics Inc
Total Revenue:
51.1m
USD
|
United States:
26.1m
USD
|
Switzerland:
14.5m
USD
|
Japan:
10.5m
USD
|
Breakdown by Segments
Repare Therapeutics Inc
See Also
What is Repare Therapeutics Inc's Revenue?
Revenue
51.1m
USD
Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Revenue amounts to 51.1m USD.
What is Repare Therapeutics Inc's Revenue growth rate?
Revenue CAGR 3Y
700%
Over the last year, the Revenue growth was -61%. The average annual Revenue growth rates for Repare Therapeutics Inc have been 700% over the past three years .